ENTERAL FORMULATIONS FOR PRETERM INFANTS COMPRISING OPTIMISED PHENYLALANINE INTAKE LEVELS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170105445A1
SERIAL NO

15312519

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to enteral formulations for preterm infants (e.g., preterm formulas and human milk fortifiers) containing optimised intake levels of phenylalanine for the preterm infants. It particularly relates to a preterm formulation comprising a proteinaceous composition, wherein the preterm formulation (a) comprises 2.0-2.29 g phenylalanine per 100 g protein; (b) comprises 64.00-82.29 mg phenylalanine per 100 kcal; and/or (c) provides, or is formulated to provide phenylalanine in an amount of 80-96 mg/kg body weight per day.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
N V NUTRICIA2712 HM ZOETERMEER

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ABRAHAMSE-BERKEVELD, Marieke Utrecht, NL 25 45
TELLER, Inga Christiane Utrecht, NL 2 0
VAN, DER BEEK Eline Marleen Utrecht, NL 47 132
VAN, GOUDOEVER Johannes Bernard Utrecht, NL 6 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation